Renal Medicine Flashcards
5 functions of the kidney
Acid-base control (pumps out H+, reabsorbs bicarb)
Regulates blood/fluid volume
Waste, toxin and drug excretion
Produces erythropoietin (stimulating red cell production)
Vitamin D metabolism (Vit D to 1-Hydroxyvit D)
How do we measure kidney function?
Creatinine:
Albumin:creatinine ration (mg/mmol)
CKD staging
1: >90 (+evidence kidney damage)
2: 60-89 (+evidence kidney damage)
3a: 45-59
3b: 30-44
4: 15-29
5: <15
Takes into account albuminuria (<3, 3-30, >30)
How does renal failure lead to anaemia?
Reduced erythropoietin production
Reduced hepcidin clearance (waste product from liver which impairs iron absorption by duodenum)
Therefore give iron supplements (IV as duodenum absorption reduced)
Nephrotic syndrome proteinuria threshold
> 3g protein excreted per 24 hours
CKD timescale
> 3 months
Which patients should be started on ARB/ACE-i?
What should their BP target be?
Diabetic and ACR >3mg/mmol
Hypertensive and ACR >30mg/mmol
ACR >70mg/mmol
Target of 130/80
Management of acute hyperkalaemia?
Calcium gluconate 10ml 10% (protects myocardium)
Followed by salbutamol, insulin and dextrose to drive potassium into cells
Role of vitamin D
Increases calcium absorption
Increases renal tubular reabsorption
Increases osteoclast activity (releasing calcium from bone)
Stages of vitamin D activation
Cholecalciferol to calcidiol by liver
Calcidiol to calcitriol by kidneys
What acid-base changes might occur in CKD?
H+ ion retention leading to acidosis - treated with sodium bicarbonate
Possible complications of CKD
Anaemia
Fluid overload
Mineral and bone disorders
Hyperkalaemia
What type of anaemia would you see in CKD and how would you manage?
Normochromic normocytic
Erythropietin-stimulating agents e.g. epoetin alfa
Indications for dialysis in AKI
Refracatory hyperkalaemia
Refractory pulmonary oedema
Severe metabolic acidosis (<7.1)
Severe uraemia (>60mmol/L or CXR)
Complications of AKI
Hyperkalaemia
Fluid overload
Metabolic acidosis
Uraemic complications (pericarditis and encephalopathy)
Rhabdomyolysis signs and symptoms
Muscle pain
Dark brown urine (myoglobinuria)
Raised CK levels
Nephrotoxic drugs
ACE-i/ARBs NSAIDs penicillin Diuretics Furosemide Rifampicin Cephalasporins
Clinical definition of oliguria?
<0.5mls/kg/hr (35mls/hr in a 70kg patient)
If this persists >6hrs then is defined as AKI
How do NSAIDs adversely affect renal function?
Inhibition of COX1/2 leading to inhibition of prostaglandin synthesis. This causes constriction of afferent arterioles and reduced renal perfusion
Promotes natriuresis (sodium excretion in urine)
How is Stage 1 AKI diagnosed?
Serum creatinine (increase by >26umol/L in 48 hours or >1.5-1.9 in 7 days)
Urine output (<0.5mls/kg/hr over 6 hours)
Pre-renal causes of AKI and what can they lead to?
Cardiac output (cardiac failure)
Arteriolar changes (nephrotoxic drugs e.g. ACE-i or NSAIDs)
Systemic vasodilation (septic shock)
Reduced circulating volume (hypovolaemia)
This can lead to intrinsic damage due to prolonged ischaemia of renal parenchyma and development of acute tubular necrosis (ATN)
Intrinsic causes of AKI
Vascular:
Large vessel: atherosclerotic disease, thromboembolic disease, dissection, renal artery stenosis/thrombosis
Small vessel: vasculitides, malignant HTN, microangiopathic haemolytic anaemia (e.g. DIC), thromboembolic disease
Glomerular: primary or secondary. Can cause nephritic/nephrotic syndrome
Tubulointerstitial: acute tubular necrosis (ATN); acute interstitial nephritis (secondary to medication)
Post-renal causes of AKI
Obstructive uropathy (urolithiasis, malignancies, strictures and bladder neck obstruction)
Clinical features of pre-renal AKI
Evidence of dehydration/hypovolaemia:
Dry mucus membranes, reduced CRT, reduced urine output, low BP, reduced skin turgor, dizziness and thirst
Hypervolaemia (due to cardiac failure):
Pulmonary/peripheral oedema, orthopnoea, paroxysmal nocturnal dyspnoea, dyspnoea, raised JVP, ascites
Acute tubular necrosis clinical features
Brown muddy casts in urine (tubular cells)
AKI features
Clinical features of tubulointerstitial disease
Arthralgia
Rashes
Fever
Eosinophilia
Clinical assessment of patient with AKI
Fluid assessment (urine output) Urine osmolality and electrolytes MSU Urine dipstick ECG
Bloods: FBC, U&Es, bone profile, blood gas
Complement, vasculitis screen (ANCA, ANA), clotting, CK, blood film, Ig
ULTRASOUND, CXR, renal doppler, MRA
When would you discuss an AKI patient with a nephrologist?
<30 GFR, or decrease by >15 in a year
ACR >70mg/mmol
Rare or genetic cause of CKD
Renal artery stenosis
Persistent HTN despite 4 anti-hypertensives
Diagnosis that may require specialist intervention (e.g. glomerulonephritis, systemic vasculitis)
Management of AKI
Regular assessment and monitoring of urine output (catheter), weight, creatinine levels compared with baseline
Hypovolaemia: IV fluids
Hypervolaemia: fluid restriction/diuretics
Hyperkalaemia: 10ml calcium gluconate 10%, 10 units ACTRAPID insulin in 20% dextrose, 2.5mg salbutamol
Acidosis: sodium bicarbonate
RRT: if refractory pulmonary oedema/hyperkalaemia, severe uraemia (leading to encephalopathy or pericarditis), metabolic acidosis
RENAL DRS 26
Record baseline creatinine and regular U%Es Obstruction excluded (USS) Urinalysis +/- MSU Nephrotoxic drugs stopped Dry (IV fluids) or wet (furosemide) Urinary output monitoring Prescription review 26 (>26umol/L serum creatinine in 48 hours for diagnosis)
Triad of nephrotic syndrome (+ other features)
- Hypoalbuminaemia
- Proteinuria (>3.5g per day)
- Oedema (low oncotic pressure)
+ coagulopathy, sepsis, hyperlipidaemia, hypocalcaemia
Rapidly progressive glomerulonephritis features
Thrombosis and rupture of capillaries leading to glomerular crescent formation in >50% of glomeruli
50% reduction in GFR over 3 months
Primary and secondary causes of nephrotic syndrome
Caused by structural changes in the glomeruli
Primary: Minimal Change Disease (commonest in children), membranous GN (commonest in adults), focal segmental glomerulosclerosis (common in adults)
Secondary: SLE, diabetes mellitus, amyloidosis
Causes of nephritic syndrome?
Proliferative: IgA nephropathy, membrano-proliferative GN, post-strep GN
Proliferative with crescents (rapidly progressing): anti-GBM, Wegener’s, microscopic polyangitis
Treatment for minimal change disease
Glucocorticoids
Immunosuppressants (cyclophosphamide) if not responding
Minimal change disease clinical features
Fusion of podocyte foot processes
Nephrotic syndrome
Normotensive
Highly selective proteinuria
PUFFY FACE
Causes of minimal change disease
Idiopathic (majority)
Drugs: NSAIDs or rifampicin
Hodgkin’s lymphoma, thymoma
infectious mononeucleosis
Causes of membranous glomerulonephritis
Thickened basement membrane
Idiopathic: anti-phospholipase A2 antibodies
Infections: hepatitis B, malaria, syphilis
Malignancy: lung cancer, leukemia
Drugs: penicillamine, NSAIDs
SLE, thyroiditis, rheumatoid
Management of membranous glomerulonephritis
ACE-i/ARBs to reduce proteinuria
Immunosuppression (corticosteroid + cyclophosphamide)
Anti-coagulation if high risk
1/3 spontaneous remission
1/3 ongoing proteinuria
1/3 ESRF
Nephritic syndrome clinical presentation
Haematuria
Mild proteinuria
HTN
Oliguria
What is nephritic urinary sediment?
Urinary red cell casts
Leucocytes
Dysmorphic red cells
Sub-nephrotic proteinuria (>3.5g/day)
Most common cause of glomerulonephritis worldwide?
IgA nephropathy